510(k) Report

FDA applicant

Endologix, Inc.

Irvine, CA9 decisions1998–202320 recalls

FDA records 9 decisions for Endologix, Inc. (Irvine, CA) from 1998 to 2023: 5 510(k) clearances and 4 original PMA approvals. Most are in product codes DYB (Introducer, Catheter) and DQY (Catheter, Percutaneous). Its devices cite 7 predicates, 4 of them its own earlier devices. 20 recalls are linked to its devices, 3 Class I.

FDA’s records also spell it “Endologix, LLC”.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, cardiovascular panel, where it files most

How often FDA has decided Endologix, Inc.’s devices, and how often a recall has named them.

FDA decisions per year

1in 2023

2008: 12011: 22012: 22023: 1
2007high 2 (2011) · low 0 (2007)2026

2026 so far, outlined.

Recalls per year

1in 2020

2012: 12013: 1, 1 Class I2014: 1, 1 Class I2016: 62017: 22020: 1, 1 Class I
2007high 6 (2016) · low 0 (2007)2026

Class I Class II/III not classified

FIG. 1 — Endologix, Inc. by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Endologix, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report